Henry Schein Inc (HSIC)

Currency in USD
88.13
-0.10(-0.11%)
Closed·
88.130.00(0.00%)
·
HSIC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
87.5788.83
52 wk Range
61.9492.18
Key Statistics
Prev. Close
88.23
Open
88.12
Day's Range
87.57-88.83
52 wk Range
61.94-92.18
Volume
649.69K
Average Volume (3m)
1.46M
1-Year Change
33.6518%
Book Value / Share
27.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HSIC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
97.56
Upside
+10.70%
Members' Sentiments
Bearish
Bullish
ProTips
9 analysts have revised their earnings downwards for the upcoming period

Henry Schein Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

9 Buy
7 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 97.56
(+10.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy100.00+13.47%86.00MaintainAug 06, 2026
UBS
Hold94.00+6.66%89.00MaintainAug 05, 2026
Stifel
Hold95.00+7.80%84.00MaintainAug 05, 2026
Piper Sandler
Buy95.00+7.80%91.00MaintainJul 29, 2026
UBS
Hold89.00+0.99%85.00MaintainJul 28, 2026

Henry Schein Inc Earnings Call Summary for Q2/2026

  • Henry Schein posted Q2 2026 non-GAAP EPS of $1.27 on revenue of $3.46B, beating estimates by 2.4% and 2.7% respectively with 6.7% sales growth.
  • Company raised FY 2026 sales guidance to 4.5%-5.5% growth from 3%-5% and lifted EPS outlook to $5.29-$5.39, citing margin expansion and productivity gains.
  • High-margin specialty products and technology segments grew 8.7% and 8.2% respectively, outpacing core business with AI-enabled software driving adoption.
  • Value-creation program targets $200M+ operating income improvement with $125M run rate by end-2026; labor cost benefits expected to begin in Q3.
  • Shares rose modestly 0.22% to $86.70 in premarket; stock trades near 52-week high with P/E of 26.17, up 23.6% year-over-year to $9.85B market cap.
Last Updated: 08/04/2026, 09:20 PM
Read Full Transcript

Earnings

Latest Release
Aug 04, 2026
EPS / Forecast
1.27 / 1.24
Revenue / Forecast
3.46B / 3.37B
EPS Revisions
Last 90 days

HSIC Income Statement

Compare HSIC to Peers and Sector

Metrics to compare
HSIC
Peers
Sector
Relationship
P/E Ratio
24.4x35.6x−0.4x
PEG Ratio
2.360.540.00
Price/Book
3.1x1.5x2.6x
Price / LTM Sales
0.7x0.9x3.0x
Upside (Analyst Target)
13.5%8.3%48.7%
Fair Value Upside
Unlock1.3%5.6%Unlock

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
54.98M49.33%4.85B
Other Institutional Investors
74.35M50.67%6.55B
Public Companies & Retail Investors
0.000.00%0.00
Total
129.33M100.00%11.4B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
KKR & Co. Inc.14.04%15,652,0321,379,414
FMR LLC6.77%7,547,458665,157

People Also Watch

165.68
GLW
+5.41%
189.52
NTAP
-1.02%
110.54
AKAM
-6.76%
236.40
CAH
-0.53%
65.77
CNC
+2.45%

FAQ

What Is the Henry Schein (HSIC) Stock Price Today?

The Henry Schein stock price today is 88.13 USD.

What Stock Exchange Does Henry Schein Trade On?

Henry Schein is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Henry Schein?

The stock symbol for Henry Schein is "HSIC."

What Is the Henry Schein Market Cap?

As of today, Henry Schein market cap is 9.83B USD.

What Is Henry Schein's Earnings Per Share (TTM)?

The Henry Schein EPS (TTM) is 3.46.

When Is the Next Henry Schein Earnings Date?

Henry Schein will release its next earnings report on Nov 03, 2026.

From a Technical Analysis Perspective, Is HSIC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Henry Schein Stock Split?

Henry Schein has split 2 times.

How Many Employees Does Henry Schein Have?

Henry Schein has 25000 employees.

What is the current trading status of Henry Schein (HSIC)?

As of Aug 08, 2026, Henry Schein (HSIC) is trading at a price of 88.13 USD, with a previous close of 88.23 USD. The stock has fluctuated within a day range of 87.57 USD to 88.83 USD, while its 52-week range spans from 61.94 USD to 92.18 USD.

What Is Henry Schein (HSIC) Price Target According to Analysts?

The average 12-month price target for Henry Schein is 97.56 USD, with a high estimate of 112 USD and a low estimate of 64 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +10.70% Upside potential.

What Is the HSIC Premarket Price?

HSIC's last pre-market stock price is 89.08 USD. The pre-market share volume is 8,640.00, and the stock has decreased by 0.85, or 0.96%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.